Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions – What FDA Would Like to See

Presenter: Katherine Wallon

REGISTER for free or LOG IN to view this content

Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions – What FDA Would Like to See

Up Next

More slides +

We Recommend